Glenn Sblendorio - 22 Dec 2021 Form 4 Insider Report for IVERIC bio, Inc.

Signature
/s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio
Issuer symbol
N/A
Transactions as of
22 Dec 2021
Net transactions value
-$882,488
Form type
4
Filing time
27 Dec 2021, 19:58:07 UTC
Previous filing
21 Dec 2021
Next filing
03 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $32,136 +22,163 +6.5% $1.45 361,296 22 Dec 2021 Direct F1
transaction ISEE Common Stock Sale $365,783 -22,163 -6.1% $16.50 339,133 22 Dec 2021 Direct F1, F2
transaction ISEE Common Stock Options Exercise $32,782 +22,608 +6.7% $1.45 361,741 23 Dec 2021 Direct F1
transaction ISEE Common Stock Options Exercise $24,919 +8,476 +2.3% $2.94 370,217 23 Dec 2021 Direct F1
transaction ISEE Common Stock Sale $527,135 -31,084 -8.4% $16.96 339,133 23 Dec 2021 Direct F1, F3
transaction ISEE Common Stock Gift $0 -20,000 -5.9% $0.000000 319,133 23 Dec 2021 Direct F4
transaction ISEE Common Stock Gift $0 -20,000 -6.3% $0.000000 299,133 23 Dec 2021 Direct F4
transaction ISEE Common Stock Gift $0 -20,000 -6.7% $0.000000 279,133 23 Dec 2021 Direct F4
transaction ISEE Common Stock Options Exercise $7,582 +5,229 +1.9% $1.45 284,362 27 Dec 2021 Direct F1
transaction ISEE Common Stock Sale $86,990 -5,229 -1.8% $16.64 279,133 27 Dec 2021 Direct F1, F6
holding ISEE Common Stock 20,000 22 Dec 2021 By trust for family member 1 F4, F5
holding ISEE Common Stock 20,000 22 Dec 2021 By trust for family member 2 F4, F5
holding ISEE Common Stock 20,000 22 Dec 2021 By trust for family member 3 F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Stock Option (Right to Buy) Options Exercise $0 -22,163 -12% $0.000000 161,337 22 Dec 2021 Common Stock 22,163 $1.45 Direct F1, F7
transaction ISEE Stock Option (Right to Buy) Options Exercise $0 -22,608 -14% $0.000000 138,729 23 Dec 2021 Common Stock 22,608 $1.45 Direct F1, F7
transaction ISEE Stock Option (Right to Buy) Options Exercise $0 -8,476 -2.1% $0.000000 391,524 23 Dec 2021 Common Stock 8,476 $2.94 Direct F1, F8
transaction ISEE Stock Option (Right to Buy) Options Exercise $0 -5,229 -3.8% $0.000000 133,500 27 Dec 2021 Common Stock 5,229 $1.45 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021.
F2 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $16.60 per share on December 22, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F3 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $17.09 per share on December 23, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F4 On December 23, 2021, the Reporting Person gifted a total of 60,000 shares of Registrant's common stock to three trusts of which the Reporting Person's immediate family members are the sole trustees and sole beneficiaries.
F5 The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F6 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $16.50 to $16.85 per share on December 27, 2021. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F7 This option was granted on December 12, 2018 and vests as follows: (1) no shares underlying the option shall vest unless, for a period of twenty consecutive trading days, the average closing sale price of the Registrant's common stock is equal to or exceeds 125% of the exercise price per share of such option (the "Performance Condition"), (2) subject to satisfaction of the Performance Condition, the option shall vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date, and (3) such stock options shall be subject to "double-trigger" acceleration of vesting upon termination of employment following a change of control in the Registrant.
F8 This option was granted on December 19, 2017 and vests with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.